CritiTech Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CritiTech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2790
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CritiTech Inc (CritiTech) is a pharmaceutical contract development manufacturing organization that specializes in particle engineering, material characterization, analytical testing, early stage drug development, pre-clinical and clinical manufacturing. The company uses Spray Drying and Supercritical Precipitation to help its customers develop their drugs. It offers contract research services such as particle engineering services, material characterization services, analytical services, and manufacturing services. CritiTech’s bioavailability optimization technology is an advanced and novel approach to the production of nanoparticulate pharmaceuticals. The company collaborates with universities, pharmaceutical companies and bio-research institutes to develop drugs. CritiTech is headquartered in Lawrence, Kansas, the US.

CritiTech Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CritiTech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CritiTech Inc, Medical Devices Deals, 2012 to YTD 2018 9
CritiTech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CritiTech Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Crititech Raises US$1.2 Million In Venture Financing 11
CritiTech Raises Additional USD0.7 Million in Venture Financing 12
CritiTech Raises US$3 Million In Venture Financing 13
Partnerships 14
DFB Pharma, CritiTech and US Biotest Form Joint Venture 14
CritiTech Enters Into Joint Venture With Finoso Pharma 15
CritiTech Inc – Key Competitors 16
CritiTech Inc – Key Employees 17
CritiTech Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
CritiTech Inc, Pharmaceuticals & Healthcare, Key Facts 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CritiTech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CritiTech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CritiTech Inc, Medical Devices Deals, 2012 to YTD 2018 9
CritiTech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Crititech Raises US$1.2 Million In Venture Financing 11
CritiTech Raises Additional USD0.7 Million in Venture Financing 12
CritiTech Raises US$3 Million In Venture Financing 13
DFB Pharma, CritiTech and US Biotest Form Joint Venture 14
CritiTech Enters Into Joint Venture With Finoso Pharma 15
CritiTech Inc, Key Competitors 16
CritiTech Inc, Key Employees 17
CritiTech Inc, Joint Venture 18

List of Figures
CritiTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CritiTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CritiTech Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[CritiTech Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neovasc Inc (NVCN)-医療機器分野:企業M&A・提携分析
    Summary Neovasc Inc (Neovasc) is a medical device company that develops, manufactures and sells products for cardiovascular disease. The company offers products such as tiara, reducer and tissue products. Its tiara is a novel transcatheter device that is designed for treating mitral regurgitation, a …
  • PCL Constructors Inc:企業の戦略的SWOT分析
    PCL Constructors Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • NTT Data Corporation:企業のM&A・事業提携・投資動向
    NTT Data Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NTT Data Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Eastman Kodak Company:戦略・SWOT・企業財務分析
    Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report Summary Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Merlin Diamonds Limited:企業の戦略・SWOT・財務情報
    Merlin Diamonds Limited - Strategy, SWOT and Corporate Finance Report Summary Merlin Diamonds Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ricerca Biosciences LLC-製薬・医療分野:企業M&A・提携分析
    Summary Ricerca Biosciences LLC (Ricerca), formerly Ricerca Inc, a subsidiary of Main Market Partners LLC, is a contract research organization that offers services to accelerate drug development. The organization's service portfolio includes drug safety and metabolism, chemical development, agrochem …
  • Carpenter Co:企業の戦略的SWOT分析
    Carpenter Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Goa Shipyard Ltd:企業の戦略・SWOT・財務分析
    Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report Summary Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析
    Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mitsubishi Materials Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Materials Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Materials Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Mesoblast Ltd (MSB):企業の財務・戦略的SWOT分析
    Mesoblast Ltd (MSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Zai Lab Ltd (ZLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Zai Lab Ltd (Zai Lab) is a biopharmaceutical company that discovers, develops and manufactures transformative medicines for cancer, autoimmune and infectious diseases. The company’s pipeline products include ZL-2306, ZL-2401, FPA144, EXT2514SUL, ZL-2301, ZL-3101, ZL-2302 and ZL-1101. It deve …
  • Esterline CMC Electronics:企業の戦略・SWOT・財務情報
    Esterline CMC Electronics - Strategy, SWOT and Corporate Finance Report Summary Esterline CMC Electronics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Paragon Offshore Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Paragon Offshore Plc (Paragon Offshore) is an oil and gas company that offers offshore drilling rigs. The company provides contract drilling, maintenance and fleet management services. It operates through a fleet of rigs including Jackup rigs, Drillships and semi submersible rigs. Paragon Of …
  • MediPal Holdings Corp:企業の戦略・SWOT・財務情報
    MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fnm Spa:企業の戦略・SWOT・財務分析
    Fnm Spa - Strategy, SWOT and Corporate Finance Report Summary Fnm Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • KELAG-Karntner Elektrizitats-Aktiengesellschaft:企業の戦略的SWOT分析
    KELAG-Karntner Elektrizitats-Aktiengesellschaft - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Sernova Corp (SVA):医療機器:M&Aディール及び事業提携情報
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • UTStarcom Holdings Corp.:企業の戦略・SWOT・財務情報
    UTStarcom Holdings Corp. - Strategy, SWOT and Corporate Finance Report Summary UTStarcom Holdings Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Groupama Assurances Mutuelles:企業の戦略・SWOT・財務分析
    Groupama Assurances Mutuelles - Strategy, SWOT and Corporate Finance Report Summary Groupama Assurances Mutuelles - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆